
Glimitab MP 1 mg/500 mg/15 mg Tablet
Marketer
Centaur Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimitab MP 1 mg/500 mg/15 mg Tablet
Combiflex DM 1 mg/500 mg/15 mg tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It promotes efficient insulin use, reducing blood sugar. Always adhere to your physician's prescribed dosage and frequency for Combiflex DM 1 mg/500 mg/15 mg tablets; take with food to prevent gastric distress. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals increases hypoglycemia risk. Regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption, as this may heighten adverse effects.
Uses of Glimitab MP 1 mg/500 mg/15 mg Tablet
Managing type 2 diabetes
Major Benefits of Glimitab MP 1 mg/500 mg/15 mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimitab MP 1 mg/500 mg/15 mg tablets should be administered with a meal.
Common Side effects of Glimitab MP 1 mg/500 mg/15 mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimitab MP 1 mg/500 mg/15 mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimitab MP 1 mg/500 mg/15 mg tablets should be administered with food.
How Glimitab MP 1 mg/500 mg/15 mg Tablet works:
Glimitab MP, a 1 mg/500 mg/15 mg tablet, combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimitab MP 1 mg/500 mg/15 mg Tablet is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitab MP 1 mg/500 mg/15 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimitab MP 1 mg/500 mg/15 mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimitab MP 1 mg/500 mg/15 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. This medication is contraindicated for those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimitab MP 1 mg/500 mg/15 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimitab MP 1 mg/500 mg/15 mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimitab MP 1 mg/500 mg/15 mg Tablet :
Should you forget to take a Glimitab MP 1 mg/500 mg/15 mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimitab MP 1 mg/500 mg/15 mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
